Title |
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
|
---|---|
Published in |
Trials, September 2020
|
DOI | 10.1186/s13063-020-04680-w |
Pubmed ID | |
Authors |
Aoife Cotter, Deborah Wallace, Cormac McCarthy, Eoin Feeney, Lorraine O’Neill, John Stack, Geraldine McCarthy, Rabia Hussain, Elena Alvarez Barco, Peter Doran, Patrick Mallon |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Ireland | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 132 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 16 | 12% |
Researcher | 15 | 11% |
Other | 11 | 8% |
Student > Ph. D. Student | 10 | 8% |
Student > Master | 10 | 8% |
Other | 21 | 16% |
Unknown | 49 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 43 | 33% |
Nursing and Health Professions | 11 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
Agricultural and Biological Sciences | 3 | 2% |
Social Sciences | 3 | 2% |
Other | 16 | 12% |
Unknown | 51 | 39% |